How does blue light cystoscopy compare to white light for finding bladder cancer lesions?
Blue light cystoscopy (BLC) uses a special dye (hexaminolevulinate, HAL) that makes cancer cells glow pink under blue light, while white light cystoscopy (WLC) is the standard method using regular white light. Studies consistently show that BLC finds more bladder cancer lesions than WLC, particularly flat, hard-to-see carcinoma in situ (CIS). This can lead to more complete tumor removal and may lower the chance of recurrence.
What the research says
A phase III study in China found that BLC detected additional bladder cancer lesions in 43.3% of patients compared to WLC alone 4. For CIS, BLC found 94.7% of lesions versus only 42.1% with WLC 4. An earlier study from 2008 reported that BLC correctly identified 97.5% of tumors, while WLC identified only 70% 10. A systematic review and meta-analysis confirmed that both BLC (photodynamic diagnosis) and narrow band imaging (NBI) have greater diagnostic sensitivity and lead to lower recurrence rates than WLC alone 9. In patients undergoing radical cystectomy, BLC had much higher sensitivity for residual disease (87.1% vs 32.3%) and for CIS (92.6% vs 29.6%) compared to WLC 11. The false-positive rate is slightly higher with BLC (around 4.9%) than with WLC (6.7%) in some studies, but the overall diagnostic accuracy is superior 1011.
What to ask your doctor
- Is blue light cystoscopy available at your hospital or clinic?
- Would I benefit from blue light cystoscopy for initial diagnosis or surveillance of bladder cancer?
- How does blue light cystoscopy affect the detection of flat lesions like carcinoma in situ (CIS)?
- Are there any extra costs or risks associated with blue light cystoscopy compared to white light cystoscopy?
- Can blue light cystoscopy help reduce the chance of my bladder cancer coming back?
This question is drawn from common patient questions about this topic and answered using cited medical research. We do not provide individualized advice.